Rarecells
Healthcare · 2010 · France
Rarecells is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests (Liquid Biospy space).
These tests are based on the ISET® platform technology that is able to extract from blood cancer cells from any type of cancer.
Cancer cells extracted by ISET® are then diagnostically identified through immune-morpho-molecular analyses combined with image analyses and AI.
This approach is believed to be a significant advancement in the highly sensitive non-invasive detection of the cancer’s signals, providing a powerful tool for early cancer detection through the identification of the first circulating cancer cells.
© 2024 YADAY - LEGAL NOTICE